Testing messages to reduce smokers' openness to using novel smokeless tobacco products

Tobacco Control

Volumn 23, Issue 4, 2014, Pages 313-321

  Popova, Lucy ^a   Neilands, Torsten B ^a   Ling, Pamela M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ADULT; ADVERTIZING; ATTITUDE TO HEALTH; CONTROLLED STUDY; FEMALE; HARM REDUCTION; HUMAN; MALE; MARKETING; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; ADVERTISING AS TOPIC; BEHAVIOR, ADDICTIVE; FEMALE; HARM REDUCTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MARKETING; MIDDLE AGED; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 84902478800     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2012-050723     Document Type: Article

References (37)

1. United States Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2012.
2. Mejia AB, Ling PM. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health 2010; 100: 78-87.
3. Federal Trade Commission. Federal trade commission smokeless tobacco report for the years 2002-2005. Washington, DC, 2007.
4. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Health effects of smokeless tobacco products. Brussels: Health and Consumer Protection Directorate-General, European Commission 2008.
5. Timberlake DS, Pechmann C, Tran SY, et al. A content analysis of Camel Snus advertisements in print media. Nicotine Tob Res 2011; 13: 431-9.
6. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-58.
7. Yatsuya H, Folsom AR. Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2010; 172: 600-5.
8. United States Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
9. International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC Press, 2007.
10. Secretan B, Straif K, Baan R, et al. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-4.
11. Persson PG, Hellers G, Ahlbom A. Use of oral moist snuff and inflammatory bowel disease. Int J Epidemiol 1993; 22: 1101-3.
12. Rogers JD, Biener L, Clark PI. Test marketing of new smokeless tobacco products in four U. S. cities. Nicotine Tob Res 2010; 12: 69-72.
13. Campaign for Tobacco-Free Kids. FTC reports show tobacco companies still spend huge sums on marketing-cigarette marketing declined, but smokeless tobacco marketing doubled in recent years. 2011.
14. Federal Trade Commission. Federal trade commission smokeless tobacco report for 2009. and 2010. Washington, DC, 2012.
15. Farrelly MC, Healton CG, Davis KC, et al. Getting to the truth: evaluating national tobacco countermarketing campaigns. Am J Public Health 2002; 92: 901-7.
16. Durkin S, Brennan E, Wakefield M. Mass media campaigns to promote smoking cessation among adults: an integrative review. Tob Control 2012; 21: 127-38.
17. National Cancer Institute. Tobacco control monograph 19: the role of the media in promoting and reducing tobacco use. Bethesda, MD: National Cancer Institute, 2008.
18. Evans WD, McCormack L. Applying social marketing in health care: communicating evidence to change consumer behavior. Med Decis Making 2008; 28: 781-92.
19. Kotler P, Roberto EL. Social marketing: strategies for changing public behavior. New York: The Free Press, 1989.
20. Bahreinifar S, Sheon NM, Ling PM. Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising. Tob Control 2013; 22: 84-90.
21. Farrelly MC, Davis KC, Haviland ML, et al. Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health 2005; 95: 425-31.
22. Malone RE, Grundy Q, Bero LA. Tobacco industry denormalisation as a tobacco control intervention: a review. Tob Control 2012; 21: 162-70.
23. Wetter DW, Cofta-Gunn L, Fouladi RT, et al. Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med 2004; 39: 1156-63.
24. Pechmann C, Shih CF. Smoking scenes in movies and antismoking advertisements before movies: effects on youth. J Mark 1999; 63: 1-13.
25. Dillard JP, Peck E. Affect and persuasion-emotional responses to public service announcements. Commun Res 2000; 27: 461-95.
26. Yzer MC, Vohs KD, Luciana M, et al. Affective antecedents of the perceived effectiveness of antidrug advertisements: an analysis of adolescents' momentary and retrospective evaluations. Prev Sci 2011; 12: 278-88.
27. Silvera DH, Austad B. Factors predicting the effectiveness of celebrity endorsement advertisements. Eur J Mark 2004; 38: 1509-26.
28. Um N-H. Exploring the effects of single vs. multiple products and multiple celebrity endorsements. J Manag Soc Sci 2008; 4: 104-14.
29. Cappella JN, Leader A, Kang Y, et al. A rating scale for visual-verbal redundancy in anti-smoking video ads: reliability and validity. San Francisco, CA: International Communication Association, 2007.
30. Green MC, Brock TC. The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol 2000; 79: 701-21.
31. Hammond D, Doxey J, Daniel S, et al. Impact of female-oriented cigarette packaging in the United States. Nicotine Tob Res 2011; 13: 579-88.
32. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1987.
33. Hammond D, Reid JL, Driezen P, et al. Pictorial health warnings on cigarette packs in the United States: an experimental evaluation of the proposed FDA warnings. Nicotine Tob Res 2013; 15: 93-102.
34. Rothman AJ, Salovey P. Shaping perceptions to motivate healthy behavior: the role of message framing. Psychol Bull 1997; 121: 3-19.
35. Rothman AJ, Bartels RD, Wlaschin J, et al. The strategic use of gain-and loss-framed messages to promote healthy behavior: how theory can inform practice. J Commun 2006; 56: S202-20.
36. Pechmann C, Reibling ET. Antismoking advertisements for youths: an independent evaluation of health, counter-industry, and industry approaches. Am J Public Health 2006; 96: 906-13.
37. Kim YJ. The role of regulatory focus in message framing in antismoking advertisements for adolescents. J Advertising 2006; 35: 143-51.